Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23,053Revenue $M803Net Margin (%)-20.4Altman Z-Score11.4
Enterprise Value $M22,732EPS $-1.1Operating Margin %-16.5Piotroski F-Score2
P/E(ttm)--Beneish M-Score-1.7Pre-tax Margin (%)-20.6Higher ROA y-yY
Price/Book9.510-y EBITDA Growth Rate %--Quick Ratio4.3Cash flow > EarningsN
Price/Sales27.35-y EBITDA Growth Rate %--Current Ratio5.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-6.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-9.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M160ROIC % (ttm)-8.0Gross Margin Increase y-yN

Gurus Latest Trades with BMRN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMRNJoel Greenblatt 2015-03-31 Buy $90.28 - $129.14
($105.95)
$ 143.7836%New holding4,195
BMRNJoel Greenblatt 2014-12-31 Sold Out $67.27 - $94.19
($83.42)
$ 143.7872%Sold Out0
BMRNJoel Greenblatt 2014-09-30 Buy $55.78 - $73
($65.82)
$ 143.78118%New holding3,885
BMRNMeridian Funds 2013-06-30 Sold Out -0.09%$54.72 - $70.3
($62.32)
$ 143.78131%Sold Out0
BMRNMeridian Funds 2013-03-31 Reduce-0.17%$49.2 - $62.39
($56.51)
$ 143.78154%Reduce 69.03%40,700
BMRNMeridian Funds 2012-12-31 Reduce-0.3%$36.78 - $50.17
($45.59)
$ 143.78215%Reduce 60.99%131,400
BMRNGeorge Soros 2012-06-30 Sold Out -0.15%$32.53 - $38.87
($36.01)
$ 143.78299%Sold Out0
BMRNGeorge Soros 2012-03-31 Add0.11%$33.68 - $38.34
($32.99)
$ 143.78336%Add 300.00%300,000
BMRNGeorge Soros 2011-12-31 Reduce-0.05%$30.07 - $35.38
($32.81)
$ 143.78338%Reduce 57.14%75,000
BMRNGeorge Soros 2011-06-30 Add0.07%$24.93 - $28.455
($26.32)
$ 143.78446%Add 862.36%191,510
BMRNMeridian Funds 2011-03-31 Reduce-0.28%$23.46 - $28.29
($25.46)
$ 143.78465%Reduce 51.54%348,800
BMRNGeorge Soros 2011-03-31 Buy 0.01%$23.46 - $28.29
($25.46)
$ 143.78465%New holding19,900
BMRNGeorge Soros 2010-09-30 Sold Out -0.02%$18.24 - $23.09
($20.93)
$ 143.78587%Sold Out0
BMRNMeridian Funds 2010-03-31 Add0.13%$18.75 - $23.81
($20.92)
$ 143.78587%Add 20.83%795,900
BMRNGeorge Soros 2010-03-31 Add$18.75 - $23.81
($20.92)
$ 143.78587%Add 35.87%30,300
BMRNGeorge Soros 2009-12-31 Buy 0.01%$15.49 - $18.98
($17.17)
$ 143.78737%New holding22,300
BMRNMeridian Funds 2009-09-30 Buy 0.53%$13.86 - $18.33
($15.84)
$ 143.78808%New holding658,700
BMRNBill Gates 2009-06-30 Sold Out -0.02%$11.92 - $15.94
($13.79)
$ 143.78943%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMRN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ajer Jeffrey RobertSVP, Chief Commercial Of 2015-07-20Sell3,000$150-4.15view
BIENAIME JEAN JACQUESCEO 2015-07-07Sell1,500$139.073.39view
SPIEGELMAN DANIEL KEVP, CFO 2015-06-05Sell1,649$122.317.56view
FUCHS HENRY JEVP, Chief Medical Officer 2015-06-05Sell1,864$122.3217.54view
Ajer Jeffrey RobertSVP, Chief Commercial Of 2015-06-04Sell1,362$122.3517.52view
SPIEGELMAN DANIEL KEVP, CFO 2015-06-01Sell5,523$124.7315.27view
Ajer Jeffrey RobertSVP, Chief Commercial Of 2015-06-01Sell377$123.7616.18view
Ajer Jeffrey RobertSVP, Chief Commercial Of 2015-05-26Sell1,625$126.5513.62view
BIENAIME JEAN JACQUESCEO 2015-05-21Sell1,500$126.114.02view
SPIEGELMAN DANIEL KEVP, CFO 2015-05-18Sell34,078$13010.6view

Quarterly/Annual Reports about BMRN:

News about BMRN:

Articles On GuruFocus.com
J.P. Morgan’s 3 Biotechnology Picks Apr 14 2015 
You Can No Longer Ignore Biotech Feb 07 2014 
Weekly Top Insider Sells: AAPL, GILD, BMRN, and PCLN Nov 19 2012 
WEEKLY CFO SELLS HIGHLIGHT: VVUS, DIS, SNPS, TXRH, BMRN Mar 04 2012 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 
BioMarin Pharmaceutical Inc. Reports Operating Results (10-K) Feb 24 2011 
BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 1,000 Shares Dec 13 2010 
BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 2,000 Shares Dec 13 2010 
BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 1,000 Shares Dec 07 2010 

More From Other Websites
BioMarin Q2 Loss Narrower than Expected, Maintains Outlook - Analyst Blog Aug 04 2015
Seven Reasons to Love Biomarin's Duchenne Drug Falls One Short Aug 04 2015
BioMarin Pharmaceutical (BMRN) Earnings Report: Q2 2015 Conference Call Transcript Aug 04 2015
Edited Transcript of BMRN earnings conference call or presentation 3-Aug-15 8:30pm GMT Aug 04 2015
Biomarin falls on earnings Aug 03 2015
BioMarin Announces Second Quarter 2015 Financial Results and Company Update Aug 03 2015
Biomarin Pharmaceutical Inc Earnings Call scheduled for 4:30 pm ET today Aug 03 2015
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 03 2015
BioMarin reports 2Q loss Aug 03 2015
BioMarin Announces Second Quarter 2015 Financial Results and Company Update Aug 03 2015
3 Biotech Stocks to Buy With Huge Catalysts Coming Soon Aug 03 2015
Q2 2015 Biomarin Pharmaceutical Inc Earnings Release - After Market Close Aug 03 2015
Will BioMarin Top Q2 Earnings Again on Vimizim Sales? - Analyst Blog Jul 31 2015
Why BioMarin Pharmaceutical (BMRN) Might Surprise This Earnings Season - Tale of the Tape Jul 30 2015
​Here are all the Boston-area biotechs about to buy or get bought Jul 29 2015
BioMarin Joins the NASDAQ-100 Index Jul 27 2015
BioMarin Joins the NASDAQ-100 Index Jul 27 2015
5 Trade Ideas for Monday: Agrium, BioMarin, Hain Celestial, Landstar & Nasdaq OMX Jul 26 2015
BioMarin Pharmaceutical Inc. to Join the NASDAQ-100 Index Beginning July 27, 2015 Jul 22 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK